Literature DB >> 34918262

Recombinant Vaccine Design Against Clostridium spp. Toxins Using Immunoinformatics Tools.

Rafael Rodrigues Rodrigues1, Marcos Roberto Alves Ferreira1, Frederico Schmitt Kremer1, Rafael Amaral Donassolo1, Clóvis Moreira Júnior1, Mariliana Luiza Ferreira Alves1, Fabricio Rochedo Conceição2.   

Abstract

The emergence of recombinant DNA technology has led to the exploration of the use of the technology to develop novel vaccines. With a fundamental role in vaccines design, several immunoinformatics tools have been created to identify isolated epitopes that stimulate a specific immune response, contributing to effective vaccines development. In the past, vaccine development projects relied entirely on animal experimentation, a relatively expensive and time-consuming process. Currently, use of immunoinformatics tools play a vital role in the antigen analysis and refinement, allowing the identification of possible protective epitopes capable of stimulating convenient humoral or cellular immune responses, in addition to facilitating time and cost reduction of vaccine production. The vaccination aimed at bacterial species of Clostridium spp. has been considered a promising example of use of these approaches in recent years. Based on the literature search, it is possible to understand the best immunoinformatics software used by researchers that facilitate recombinant vaccine antigens design and development. This chapter presents an overview of how these tools are supporting the antigen engineering, aiming at increasing the efficiency of inducing protective immune response in animals.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioinformatics; Clostridiosis; Recombinant antigens; Recombinant vaccines

Mesh:

Substances:

Year:  2022        PMID: 34918262     DOI: 10.1007/978-1-0716-1892-9_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Immunoinformatic analysis of the whole proteome for vaccine design: An application to Clostridium perfringens.

Authors:  Luis F Soto; Ana C Romaní; Gabriel Jiménez-Avalos; Yshoner Silva; Carla M Ordinola-Ramirez; Rainer M Lopez Lapa; David Requena
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

2.  Immunogenicity of a newly developed vaccine against Clostridium perfringens alpha-toxin in rabbits and cattle.

Authors:  Mohamed J Saadh; Feras F Lafi; Adnan A Dahadha; Mohamed S Albannan
Journal:  Vet World       Date:  2022-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.